0.5432
price down icon6.15%   -0.0356
after-market アフターアワーズ: .58 0.0368 +6.77%
loading
前日終値:
$0.5788
開ける:
$0.6
24時間の取引高:
421.26K
Relative Volume:
0.31
時価総額:
$116.68M
収益:
-
当期純損益:
$-41.23M
株価収益率:
-0.776
EPS:
-0.7
ネットキャッシュフロー:
$-11.54M
1週間 パフォーマンス:
-24.40%
1か月 パフォーマンス:
-44.72%
6か月 パフォーマンス:
+12.39%
1年 パフォーマンス:
-79.50%
1日の値動き範囲:
Value
$0.5432
$0.6118
1週間の範囲:
Value
$0.5432
$0.7338
52週間の値動き範囲:
Value
$0.395
$3.05

Renovaro Inc Stock (RENB) Company Profile

Name
名前
Renovaro Inc
Name
セクター
Healthcare (1164)
Name
電話
45 39179840
Name
住所
CENTURY CITY MEDICAL PLAZA, SUITE 906 LOS ANGELES
Name
職員
0
Name
Twitter
Name
次回の収益日
2024-11-12
Name
最新のSEC提出書
Name
RENB's Discussions on Twitter

RENB を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
RENB
Renovaro Inc
0.5432 116.68M 0 -41.23M -11.54M -0.70
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
484.82 131.41B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
634.23 72.26B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
591.87 36.10B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
270.02 35.03B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
272.17 28.24B 3.81B -644.79M -669.77M -6.24

Renovaro Inc (RENB) 最新ニュース

pulisher
Mar 30, 2025

Bank of New York Mellon Corp Grows Stake in Renovaro Inc. (NASDAQ:RENB) - Defense World

Mar 30, 2025
pulisher
Mar 21, 2025

PawTides.com Partners with Rescue 22 Foundation to Support Veterans and Rescue Dogs - openPR

Mar 21, 2025
pulisher
Mar 11, 2025

Rhumbline Advisers Acquires 62,204 Shares of Renovaro Inc. (NASDAQ:RENB) - Defense World

Mar 11, 2025
pulisher
Mar 07, 2025

New York State Common Retirement Fund Trims Stake in Renovaro Inc. (NASDAQ:RENB) - Defense World

Mar 07, 2025
pulisher
Mar 04, 2025

Predictive Oncology receives financing from Renovaro Biosciences - Pennsylvania Business Report -

Mar 04, 2025
pulisher
Mar 04, 2025

Renovaro (RENB) and Predictive Oncology Partner for AI-Driven Drug Discovery: What’s Next for Cancer and HIV Treatments? - Yahoo Finance

Mar 04, 2025
pulisher
Mar 03, 2025

Sea (SE) Reports Q4: Everything You Need To Know Ahead Of Earnings - The Globe and Mail

Mar 03, 2025
pulisher
Mar 03, 2025

Renovaro provides financing to Predictive Oncology as both move to finalize definitive merger agreement - The Business Journals

Mar 03, 2025
pulisher
Mar 03, 2025

MarketsMedicine Hat News - Financial Content

Mar 03, 2025
pulisher
Mar 03, 2025

Milestone Merger Payment made with Predictive Oncology to Advance AI-Driven Biomarker Discovery and Precision Medicine in Cancer and Beyond: Renovaro, Inc. (NASDAQ: RENB) - The Globe and Mail

Mar 03, 2025
pulisher
Mar 03, 2025

What To Expect From Best Buy’s (BBY) Q4 Earnings - The Globe and Mail

Mar 03, 2025
pulisher
Mar 03, 2025

Milestone Merger Payment made with Predictive Oncology - openPR

Mar 03, 2025
pulisher
Mar 03, 2025

Renovaro Completes First Milestone Payment To Finalize Definitive Agreement With Predictive Oncology - Marketscreener.com

Mar 03, 2025
pulisher
Mar 03, 2025

Renovaro Completes First Milestone Payment to Finalize Definitive Agreement with Predictive Oncology - GlobeNewswire

Mar 03, 2025
pulisher
Mar 03, 2025

Predictive Oncology Moves To Finalize Definitive Merger Agreement With Renovaro Biosciences - Marketscreener.com

Mar 03, 2025
pulisher
Mar 03, 2025

Predictive Oncology Moves to Finalize Definitive Merger Agreement With Renovaro Biosciences - The Manila Times

Mar 03, 2025
pulisher
Mar 03, 2025

Renovaro Biosciences Advances Financing for AI-Driven Integration and Strategic Expansion in Oncology through Acquisition of Predictive Oncology - Nasdaq

Mar 03, 2025
pulisher
Mar 03, 2025

Can Renovaro's AI Oncology Merger Unlock Value From 150,000+ Tumor Samples? - StockTitan

Mar 03, 2025
pulisher
Mar 03, 2025

Can This AI-Powered Oncology Merger Transform Cancer Treatment? First Financing Milestone Reached - StockTitan

Mar 03, 2025
pulisher
Feb 28, 2025

Renovaro Stock Price, Quotes and Forecasts | NASDAQ:RENB - Benzinga

Feb 28, 2025
pulisher
Feb 28, 2025

Renovaro Biosciences Announces Merger with BioSymetrics - TipRanks

Feb 28, 2025
pulisher
Feb 28, 2025

Rocket Lab Stock Is Down 30% in the Last Month. Should You Buy the Dip or Run Far Away? - The Globe and Mail

Feb 28, 2025
pulisher
Feb 28, 2025

Renovaro announces $15 million in equity - MSN

Feb 28, 2025
pulisher
Feb 27, 2025

Renovaro Inc. (RENB) Merges with BioSymetrics to Advance AI-Driven Cancer Research - Insider Monkey

Feb 27, 2025
pulisher
Feb 26, 2025

Renovaro Announces $15 million in Equity Committed - GlobeNewswire

Feb 26, 2025
pulisher
Feb 26, 2025

Renovaro secures $15 million for cancer AI technology By Investing.com - Investing.com Australia

Feb 26, 2025
pulisher
Feb 26, 2025

Enochian Biosciences Stock: AI-Powered Merger Fuels Growth - sharewise

Feb 26, 2025
pulisher
Feb 26, 2025

Sector Update: Health Care -February 26, 2025 at 03:37 pm EST - Marketscreener.com

Feb 26, 2025
pulisher
Feb 26, 2025

Merger Agreement with BioSymetrics to Accelerate Biomarker Identification, Enhance Drug Discovery and Expand Precision Medicine Applications in Advanced Cancer Diagnosis and Treatment | FinancialContent Business Page - FinancialContent

Feb 26, 2025
pulisher
Feb 26, 2025

Renovaro and BioSymetrics merge to boost AI-driven drug discovery - Investing.com

Feb 26, 2025
pulisher
Feb 26, 2025

Renovaro and BioSymetrics merge to boost AI-driven drug discovery By Investing.com - Investing.com South Africa

Feb 26, 2025
pulisher
Feb 26, 2025

$15 Million in New Equity to Support Advanced Cancer Diagnostics, Personalized Immunotherapy, Treatments & Drug Discovery: Renovaro Stock Symbol: RENB - WICZ

Feb 26, 2025
pulisher
Feb 26, 2025

Renovaro Agrees to Merge With BioSymetrics -February 26, 2025 at 01:47 pm EST - Marketscreener.com

Feb 26, 2025
pulisher
Feb 26, 2025

Renovaro & Biosymetrics Announce Definitive Merger Agreement -February 26, 2025 at 01:27 pm EST - Marketscreener.com

Feb 26, 2025
pulisher
Feb 26, 2025

Renovaro and BioSymetrics Announce Definitive Merger - GlobeNewswire

Feb 26, 2025
pulisher
Feb 26, 2025

Renovaro and BioSymetrics Announce Definitive Merger Agreement to Advance AI-Driven Biomarker Discovery and - EIN News

Feb 26, 2025
pulisher
Feb 26, 2025

Renovaro Gets $15 Million in Equity Committed; Shares Rise -February 26, 2025 at 10:58 am EST - Marketscreener.com

Feb 26, 2025
pulisher
Feb 26, 2025

Renovaro secures $15 million for cancer AI technology - Investing.com

Feb 26, 2025
pulisher
Feb 26, 2025

Renovaro Inc. Secures $15 Million in Additional Equity to Advance Cancer Diagnostics and Therapeutics - Nasdaq

Feb 26, 2025
pulisher
Feb 26, 2025

Can $15M in Fresh Funding Help Renovaro Transform Cancer Treatment with AI? - StockTitan

Feb 26, 2025
pulisher
Feb 26, 2025

Merger Agreement with BioSymetrics to Accelerate Biomarker Identification, Enhance Drug Discovery and Expand Precision Medicine Applications in Advanced Cancer Diagnosis and Treatment - The Globe and Mail

Feb 26, 2025
pulisher
Feb 20, 2025

Renovaro (NASDAQ:RENB) Posts Earnings Results - MarketBeat

Feb 20, 2025
pulisher
Feb 20, 2025

Investors Eye Biotech Sector as Cancer Therapy Market Surges - KamloopsBCNow

Feb 20, 2025
pulisher
Feb 20, 2025

Renovaro: Fiscal Q2 Earnings Snapshot - CTPost

Feb 20, 2025
pulisher
Feb 19, 2025

Renovaro: Fiscal Q2 Earnings Snapshot -February 19, 2025 at 05:03 pm EST - Marketscreener.com

Feb 19, 2025
pulisher
Feb 19, 2025

RENOVARO INC. SEC 10-Q Report - TradingView

Feb 19, 2025
pulisher
Feb 19, 2025

Some Of Renovaro's Financial Statements Contain Material Misstatements, SEC Filing Shows - Marketscreener.com

Feb 19, 2025

Renovaro Inc (RENB) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$70.69
price down icon 1.05%
$76.29
price down icon 2.18%
$31.13
price down icon 0.77%
$19.29
price down icon 5.07%
$91.06
price down icon 4.10%
biotechnology ONC
$272.17
price up icon 1.79%
大文字化:     |  ボリューム (24 時間):